These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20473926)

  • 1. Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP.
    Weiss JV; Klein-Scory S; Kübler S; Reinacher-Schick A; Stricker I; Schmiegel W; Schwarte-Waldhoff I
    Int J Cancer; 2011 Mar; 128(6):1384-92. PubMed ID: 20473926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum soluble E-cadherin in colorectal carcinoma.
    Okugawa Y; Toiyama Y; Inoue Y; Iwata T; Fujikawa H; Saigusa S; Konishi N; Tanaka K; Uchida K; Kusunoki M
    J Surg Res; 2012 Jun; 175(2):e67-73. PubMed ID: 22277332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
    Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
    Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.
    Chan AO; Lam SK; Chu KM; Lam CM; Kwok E; Leung SY; Yuen ST; Law SY; Hui WM; Lai KC; Wong CY; Hu HC; Lai CL; Wong J
    Gut; 2001 Jun; 48(6):808-11. PubMed ID: 11358900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma.
    Bernhard OK; Greening DW; Barnes TW; Ji H; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2372-9. PubMed ID: 23557862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
    El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
    J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.
    Tsaur I; Thurn K; Juengel E; Gust KM; Borgmann H; Mager R; Bartsch G; Oppermann E; Ackermann H; Nelson K; Haferkamp A; Blaheta RA
    J Exp Clin Cancer Res; 2015 May; 34(1):43. PubMed ID: 25967040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients.
    Wilmanns C; Grossmann J; Steinhauer S; Manthey G; Weinhold B; Schmitt-Gräff A; von Specht BU
    Clin Exp Metastasis; 2004; 21(1):75-8. PubMed ID: 15065605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular domain of E cadherin linked to invasiveness in colorectal cancer: a new resistance and relapses monitoring serum-bio marker?
    Christou N; Perraud A; Blondy S; Jauberteau MO; Battu S; Mathonnet M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1177-1190. PubMed ID: 28289897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
    Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Wereszczyńska-Siemiatkowska U; Kedra B; Lukaszewicz M; Baniukiewicz A; Szmitkowski M
    Clin Chem Lab Med; 2008; 46(10):1423-8. PubMed ID: 18844497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.